These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9331631)

  • 1. Streptococcal toxic shock syndrome (STSS). An update: a roundtable presentation.
    Holm SE; Köhler W; Kaplan EL; Schlievert PM; Alouf JE; Stevens DL; Kotb M
    Adv Exp Med Biol; 1997; 418():193-9. PubMed ID: 9331631
    [No Abstract]   [Full Text] [Related]  

  • 2. Superantigenic activity produced by group A streptococcal isolates is neutralized by plasma from IVIG-treated streptococcal toxic shock syndrome patients.
    Norrby-Teglund A; Low DE; McGeer A; Kotb M
    Adv Exp Med Biol; 1997; 418():563-6. PubMed ID: 9331714
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytokine profile of human peripheral blood mononucleated cells stimulated with a novel streptococcal superantigen, SPEA, SPEC and group A streptococcal cells.
    Müller-Alouf H; Capron M; Alouf JE; Geoffroy C; Gerlach D; Ozegowski JH; Fitting C; Cavaillon JM
    Adv Exp Med Biol; 1997; 418():929-31. PubMed ID: 9331802
    [No Abstract]   [Full Text] [Related]  

  • 4. [Superantigens and toxic shock syndrome. A report of three cases treated with intravenous gammaglobulin].
    Vázquez García RE; Hernández Bautista V; Espinosa Padilla S
    Rev Alerg Mex; 2006; 53(5):183-8. PubMed ID: 17357565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superantigens and streptococcal toxic shock syndrome.
    Proft T; Sriskandan S; Yang L; Fraser JD
    Emerg Infect Dis; 2003 Oct; 9(10):1211-8. PubMed ID: 14609454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing group A streptococci. The reappearance of streptococcal 'toxic shock'.
    Stollerman GH
    Arch Intern Med; 1988 Jun; 148(6):1268-70. PubMed ID: 3288156
    [No Abstract]   [Full Text] [Related]  

  • 7. Streptococcal toxic shock syndrome.
    Köhler W
    Zentralbl Bakteriol; 1990 Mar; 272(3):257-64. PubMed ID: 2184817
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study.
    Linnér A; Darenberg J; Sjölin J; Henriques-Normark B; Norrby-Teglund A
    Clin Infect Dis; 2014 Sep; 59(6):851-7. PubMed ID: 24928291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'Toxic strep syndrome'. A manifestation of group A streptococcal infection.
    Bartter T; Dascal A; Carroll K; Curley FJ
    Arch Intern Med; 1988 Jun; 148(6):1421-4. PubMed ID: 3288161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Surprises of streptococcal infection].
    Beliakov VD
    Vestn Ross Akad Med Nauk; 1996; (11):24-8. PubMed ID: 9011276
    [No Abstract]   [Full Text] [Related]  

  • 11. Rationale for the use of intravenous gamma globulin in the treatment of streptococcal toxic shock syndrome.
    Stevens DL
    Clin Infect Dis; 1998 Mar; 26(3):639-41. PubMed ID: 9524836
    [No Abstract]   [Full Text] [Related]  

  • 12. Streptococcal toxic shock-like syndrome as a complication of varicella.
    Bradley JS; Schlievert PM; Sample TG
    Pediatr Infect Dis J; 1991 Jan; 10(1):77-9. PubMed ID: 2003062
    [No Abstract]   [Full Text] [Related]  

  • 13. [Case of severe streptococcus pyogenes pneumonia with streptococcus toxic shock syndrome].
    Izumiyama N; Miki H; Shishikura Y; Kawaguchi C; Saitou W; Kikuchi T; Kumagai K; Sasamori K; Kikuchi Y
    Nihon Kokyuki Gakkai Zasshi; 2008 Jun; 46(6):488-92. PubMed ID: 18592996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome.
    Darenberg J; Söderquist B; Normark BH; Norrby-Teglund A
    Clin Infect Dis; 2004 Mar; 38(6):836-42. PubMed ID: 14999628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulin therapy for toxic shock syndrome.
    Barry W; Hudgins L; Donta ST; Pesanti EL
    JAMA; 1992 Jun; 267(24):3315-6. PubMed ID: 1597914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lethal shock induced by streptococcal pyrogenic exotoxin A in mice transgenic for human leukocyte antigen-DQ8 and human CD4 receptors: implications for development of vaccines and therapeutics.
    Welcher BC; Carra JH; DaSilva L; Hanson J; David CS; Aman MJ; Bavari S
    J Infect Dis; 2002 Aug; 186(4):501-10. PubMed ID: 12195377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell activation and cytokine release in streptococcal toxic shock-like syndrome.
    Nadal D; Lauener RP; Braegger CP; Kaufhold A; Simma B; Lütticken R; Seger RA
    J Pediatr; 1993 May; 122(5 Pt 1):727-9. PubMed ID: 8496751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunctive treatment of streptococcal toxic shock syndrome using intravenous immunoglobulin: case report and review.
    Perez CM; Kubak BM; Cryer HG; Salehmugodam S; Vespa P; Farmer D
    Am J Med; 1997 Jan; 102(1):111-3. PubMed ID: 9209207
    [No Abstract]   [Full Text] [Related]  

  • 19. Invasive group A streptococcal disease. Association with a lack of anti-exotoxin antibodies.
    Mascini EM; Hazenberg MM; van Dalen A; Verhoef-Verhage LA; van Leeuwen NJ; Verhoef J; van Dijk H
    Adv Exp Med Biol; 1997; 418():921-2. PubMed ID: 9331799
    [No Abstract]   [Full Text] [Related]  

  • 20. Streptococcal puerperal sepsis and obstetric infections: a historical perspective.
    Charles D; Larsen B
    Rev Infect Dis; 1986; 8(3):411-22. PubMed ID: 3523698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.